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Patients with congestive heart failure (CHF) are at increased risk for hospital readmission 
within 30 days of discharge. The gap in practice involves the coordination of care for 
patients with CHF in the transition from hospital to home. Patients with CHF are at 
increased risk for hospital readmission due to barriers involving self-care, 
communication, and coordination of care. The purpose of this project was to implement a 
clinical practice guideline (CPG) that used a predictive tool and clinical pathway for 
coordination of care for CHF patients at increased risk for hospital readmission within 30 
days. The DNP project involved using the chronic care model as a framework and 
addressed the practice-focused question, which asked whether the CPG would be 
accepted by an expert panel for full implementation. The CPG was presented to a 9-
member expert panel, all members of a larger QI readmission task force. There were 5 
cardiac providers, and 4 nursing or administrative leaders with decision-making abilities 
at the site. Scores on the Agree II instrument from nine experts ranged from 5.5 to 6.81 
across 23 items and 6 domains indicating overall agreement on the CPG. 
Recommendations of the panel included a change to the clinical practice guideline to 
reflect ischemic workup and criteria for admission when a patient presents to the 
emergency department. The expert panel agreed to full implementation of the CPG. The 
impact of this CPG will lead to decreased needs for hospital readmission, improved 
coordination of care, improved communication between the patient and the healthcare 
team, and empowerment of patients, leading to positive social change in terms of caring 
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Section 1: Nature of the Project 
Introduction 
Heart failure is a significant cause of morbidity and mortality and is one of the 
leading causes of hospital admission and readmission. These readmissions affect more 
than a million patients annually, and anticipated healthcare spending is expected to 
eclipse $69.7 billion in 2030 (Zohrabian, Kapp, & Simoes, 2018). The Centers for 
Medicare and Medicaid Services (CMS) began reviewing heart failure readmission rates 
in 2012 and implemented penalties to hospitals with increased 30-day all-cause 
readmissions (CMS, 2019). Although there have been advances in the reduction of 
unnecessary hospital readmissions, many of these readmissions may be avoided when 
guideline-directed therapies are implemented in a timely, practical, or patient-centered 
manner (Gordin & Fonarow, 2016; Greene et al., 2018). Working to improve quality of 
life for patients with chronic illness begins with understanding what influences contribute 
to hospital admission and readmission. Each hospital readmission places the patient at 
increased risk for complications such as hospital-acquired illnesses and stress, while also 
placing additional financial burdens on patients (Fingar & Washington, 2015). The 
application of clinical guidelines allows for improving the patient experience while 
optimizing care. Creating treatment plans that incorporate current evidence into daily 
practice enables practitioners to develop individualized treatment plans while improving 
the lives of patients. 
The financial burden of hospital readmission for heart failure exacerbates after 30 




readmission, develop methods to predict heart failure readmission, and evaluate strategies 
to prevent unnecessary readmission (Kitsiou, Paré, & Jaana, 2015). To decrease 
unnecessary hospital readmission and improve quality of life for patients with congestive 
heart failure (CHF), the DNP clinical practice guideline (CPG) incorporates evidence-
based practice into recommendations of care for patients with CHF, through coordination 
of care from the acute care setting to the ambulatory setting. This process is intended to 
decrease heart failure readmission by optimizing patient care and overcoming barriers 
that lead to unnecessary hospital readmission (Fischer et al., 2016). 
To further understand the need for hospital admission or risk for readmission in 
CHF patients, it is imperative to determine the barriers that these patients face. These 
readmissions are often multifactorial and related to a lack of appropriate discharge 
planning, patient education, communication, and transition of care planning (Wood, 
Migliore, Nasshan, Mirghani, & Contasti, 2019). Because of the multidisciplinary nature 
of inpatient hospital care, gaps in practice can result in readmission. If patients are not 
prepared at the time of discharge with adequate resources to bridge the transition from the 
inpatient setting to the next setting (home, long-term care, or subacute rehabilitation), the 
risk for readmissions increases. Programmatic changes have been developed as solutions. 
National initiatives detailed by CMS, have provided a foundation for creating processes 
focused on medication management, discharge planning, close follow up after discharge, 
and ongoing performance monitoring (Milfred-LaForest et al., 2017). Thus, the DNP 
project will involve using these existing strategies to construct a CPG for presentation to 




quality of life for patients as well as reduce the overall cost of caring for these patients, 
contributing to positive social change. 
Problem Statement 
Healthcare systems have been experiencing increased readmission rates for 
patients with CHF, with a projected increase in the future due to the number of patients 
affected by this chronic illness. Readmission rates for 2018 in patients with heart failure 
are higher than the national average of 21.7%, at one of five acute care hospitals within 
the network. Current readmission rates are 21.78%, which is 4-6% higher than the other 
four facilities in the system. Although the current 30-day readmission rate is at pace with 
the national average, it still results in penalties to revenue for the organization and costs 
to patients. The consequences to patients and the organization are both substantial. The 
cost of care for each of these readmissions is approximately $10,100 to $14,200 and may 
vary depending on the patient’s insurance (Bailey, Weiss, Barrett, & Jiang, 2019). There 
were 326 patients identified as readmitted within 30-days of discharge in this 1-year 
period of time. Of these patients, more than half were discharged to home or self-care 
following their admission. In addition, patients transferred to home with home care and 
transitioned to long-term care were also included in the 1-year sample. Reducing hospital 
readmission aligns with practice site goals and healthcare initiatives, affects healthcare 
and healthcare systems financially, and positively impacts lives of patients and their 
families. Patients may find it challenging to understand their medical diagnosis due to 
complexity, lack of social support, or difficulty maneuvering through the healthcare 




Factors that negatively affect patients following hospital admission or 
readmission are often related to lifestyle modification. In addition to dietary and 
medication compliance, patients with CHF may experience complications due to 
decompensation of their illness during hospital admission. Morrison, Palumbo, and 
Rambur (2016) said that CHF patients are at increased vulnerability within the first 
weeks from discharge. Home visits occurred within the first 24 to 48 hours post-
discharge, with the implementation of interventions applicable to reduce short-term and 
long-term hospital readmission. Initial assessments included a comprehensive physical 
examination, medication reconciliation, and patient education involving self-management 
of the disease. In addition, transitional care focused on the evaluation of additional needs 
related to home care, transportation, and nutritional needs (Morrison, Palumbo, & 
Rambur, 2016). Helping patients understand the importance of self-care, lifestyle 
modifications, and overcoming potential barriers will improve quality of life for these 
patients and their families.  
Purpose Statement 
The need to reduce hospital readmission in patients with CHF represents a gap in 
practice. Even with the use of predictive models, transitional care clinics, and close 
follow up, readmission rates remain elevated beyond the national average. There may be 
barriers to self-care that patients experience, such as lack of transportation, insufficient 
financial means for medication, or deficient dietary regimens; organizational processes 
do not address these barriers. Current processes do not anticipate patient questions that 




current health status. There are communication deficits in terms of the transition of care 
that exist between the hospitalist, case manager, discharging nurse, and social services 
following discharge. 
These gaps in practice identified are related to transition of care for patients with 
CHF from hospital to home. The purpose of the DNP project was to develop and 
implement a CPG using a risk stratification tool, evidence-based practice guidelines for 
CHF, heart failure order sets, and transitional care services designed specifically for 
patients with CHF. Hospital readmission rates currently exceeding the national average 
may not be reflective of the care provided. Thus, the practice-focused question that will 
help to close the gap in practice is: Will a transition of care practice guideline be accepted 
for full implementation by an expert panel at this site as a strategy to reduce this 30-day 
readmission rate in CHF patients?? 
A transitional care clinic was implemented in May 2019 to assist with the 
transition from hospital to home. In the initial evaluation of the use of the post-discharge 
clinic in October 2019, more than 130 patients had been admitted with CHF, and only 
two patients had participated in the use of the transitional care clinic, representing an 
additional gap in transitional services. Barriers preventing self-care at home included lack 
of transportation to the clinic, lack of knowledge of appointment at the time of discharge, 
and inconsistent discharge instructions. Patients could benefit from the use of visiting 
nursing services post-discharge; however, these services may not be fully taken 




A CPG incorporates the use of patient education, communication, and transitional 
care development to assist in the coordination of care from acute care to ambulatory 
settings. Each member of the healthcare team must work to effectively transition patients 
to the home setting while decreasing their risk for readmission. Donaho et al. (2015) 
noted that involving the care team during hospital admission improves communication 
while creating the expectation of continuity of care. The practice guideline project allows 
for the creation of a comprehensive care approach to assist patients in the transition to 
home and will close the current gap in practice at the site.  
Nature of the Doctoral Project 
Multiple factors may influence hospital readmission. Ryan, Bierle, and Vuckovic 
(2019) noted that the transition of care should be individualized and multifaceted due to 
the complexity of CHF patients. The DNP project involved the development of a CPG 
intended to improve patients’ health by providing therapies based on clinical evidence. 
The development of a CPG involved the use of multidisciplinary teams following a 
comprehensive review of the evidence. The use of a CPG empowered staff to facilitate 
shared decision making, identify gaps in practice, and overcome barriers to care.  
Hospital readmission is attributed to the discharge process as patients transition 
from hospital to home, which involves access to care, inconsistencies in discharge 
instructions, and insufficient education in the self-management of the disease process. 
Current processes allow for initial risk stratification of patients with chronic diseases; 
however, outcomes of this risk stratification are unclear. Using a risk stratification model, 




of admission (A), comorbidities (C), and emergency department visits (E). This score 
provides objective criteria for the prediction of hospital readmission (Miller, Nguyen, 
Vangala, & Dowling, 2018). The current use of the LACE index tool at the practice site 
is unclear; however, through the CPG, the transition of care process will actively include 
the use of this predictive score. 
As part of the transition of care, the OPTIMIZE-HF and Get with the Guidelines-
Heart Failure (GWTG-HF) demonstrated a reduction in 30-day readmission rates when 
CHF patients were evaluated within 7 days from discharge (Blood, Fraiche, & Eapen, 
2017). In addition to follow up within 7 days from discharge, designated transitional care 
paperwork should include the medical diagnosis, current medication regimen, diagnostic, 
and pending workup. Alternative strategies, such as telemonitoring of patients with heart 
failure, providing diagnostic evidence of fluid changes resulting in changes in pulmonary 
pressures or thoracic impedance may be necessary in the days to weeks preceding 
exacerbation of symptoms (Murphy, Shanks, & Alderman, 2019). Coordination of care 
when transitioning patients to home, use of telemonitoring, and close followup allows for 
early intervention and adjustments in treatment plans. Implementation of the CPG 
supported by evidence-based practice allows for transitional care from hospital to home 
and facilitates communication between patients and their healthcare team. The objective 






This project is intended to have a positive impact on primary stakeholders, 
including patients, families, organizations, healthcare providers, nursing administration, 
and quality improvement teams. Secondary stakeholders of the DNP project include 
interdisciplinary teams comprised of acute care team members from case management, 
acute care cardiac rehabilitation, nursing, hospitalist teams, cardiologists and cardiology 
advanced practice providers (APPs), and pharmacy staff. 
In addition to these teams, ambulatory stakeholders included ambulatory staff 
(i.e., transitional care nursing, ambulatory cardiac rehab, ambulatory case management, 
and ambulatory nursing staff). These teams improve the lives of CHF patients when 
engaged in a CPG that bridges gaps in practice. This guideline focuses on optimizing 
medical therapies and transitioning care, while overcoming barriers to care for this 
patient population to decrease the risk for unnecessary hospital readmissions.  
Summary 
Patients with CHF are at increased risk for hospital admission and readmission. 
This disease affects more than 6.5 million individuals in the United States, leading to 
annual healthcare expenditures of more than $39 billion (Donaho et al., 2015). Much of 
this cost is related to unnecessary hospital readmission for patients with a primary or 
secondary diagnosis of CHF. Healthcare teams play a role in reducing these hospital 
readmissions through the ongoing management of patients. The gap in practice identified 
inconsistencies in transitional care leading to hospital readmission. The purpose of the 




define the transition of care process for CHF patients at the site. This guideline has the 
potential to prevent or reduce 30-day hospital readmissions, improving patients’ quality 
of life, and reducing costs of care. Section 2 will provide a link to concepts, models, and 
theories, as well as relevance of nursing practice from the published literature to provide 




Section 2: Background and Context 
Introduction 
Heart failure is a significant cause of morbidity and mortality, and one of the 
leading causes of hospital admission and readmission. These readmissions affect more 
than a million patients annually, accounting for more than $1.7 billion in healthcare 
spending (Mirkin, Enomoto, Caputo, & Hollenbeak, 2017). Noting the magnitude of this 
issue, CMS began reviewing heart failure readmission rates and implemented penalties to 
hospitals with increased 30-day all-cause readmissions, creating the foundation for the 
Hospital Readmission Reduction Program (HRRP) (CMS, 2019). While there have been 
advances in the reduction of unnecessary hospital readmissions, many of these 
readmissions may be avoided when guideline-directed therapies are implemented in a 
timely, practical, or patient-centered manner (Ryan, Bierle, & Vuckovic, 2019). Working 
to improve quality of life for patients with chronic illnesses begins with understanding 
influences that contribute to hospital admission and readmission.  
The practice focus question addressed was: Will a transition of care practice 
guideline be accepted for full implementation by an expert panel at this site as a strategy 
to reduce this 30-day readmission rate in CHF patients? The gap in practice involves 
readmission rates, which at this practice site remain elevated beyond the national average 
of 21.7%. The purpose of the DNP project is to bridge the gap in practice through a 





Concepts, Models, and Theories 
CHF is a chronic disease requiring ongoing daily management that leads to an 
increased risk for hospital readmission. With the establishment of the HRRP by the CMS 
in 2012, hospitals may be penalized with reduced payments with increased 30-day 
readmission rates. Due to this initiative, healthcare systems have been evaluating 
methods to identify patients who may be at risk and implementing interventions that 
potentially reduce the need for hospital readmission in patients with CHF. Reduction of 
risks for hospital readmission requires a multifaceted approach. This CPG involves using 
predictive risk models to risk-stratify patients, identify patient and system barriers, and 
identify methods to overcome these barriers.  
Predicting Risk of Readmission 
Flanagan et al. (2018) conducted a retrospective medical record review to 
evaluate factors that lead to hospital readmission. Identification of individual behaviors, 
such as social support needs assessment. These health behaviors influenced the likelihood 
of hospital readmission. It was also noted that patients with chronic CHF compared to a 
new onset diagnosis are 2.5 times increase the risk for readmission. Additional 
assessments of these patients, using risk assessment tools such as the Braden skin score, 
showed that patients with increased Braden scores are at 20 times increased risk for 
readmission. Thus, demonstrating the need for comprehensive risk assessment prior to 
discharge from the acute care setting (Flanagan et al., 2018).  
Ritt and Taylor (2016) conducted a descriptive non-experimental study, 




tool in predicting hospital readmission in patients with CHF. This LACE index score 
demonstrates objective data demonstrating the potential risk for hospital readmission. 
Implemented at hospital admission, it allows for identification of patients who are at 
moderate to high risk for readmission. Patients with elevated scores demonstrate not only 
potential risks for hospital readmission but an increased risk of early death after discharge 
from the acute care facility.  
Mirkin, Enomoto, Caputo, and Hollenbeak (2017) used administrative discharge 
data, detailed patient variables: including age, gender, and race, as well as diagnosis and 
procedure codes to determine risk for readmission. Additional characteristics of CHF 
patients that demonstrated that increased the risk for readmission included those who 
were readmitted from home, less than 65 years in age, black race/ethnicity, have an 
increased length of stay, demonstrate an emergent admission, and have an increased 
comorbidity burden. Factors that may influence readmission include sociodemographic 
discriminators of male sex, age, black race, and Medicare insurance is associated with 
increased risk for readmission 
Miller et al. (2018) evaluated the use of a 3-question survey compared to the 
LACE index tool to assess provider ability to predict a patient’s risk for readmission. 
Both the LACE index and the provider's assessment demonstrated predictive values in 
determining the potential for readmission; however, the LACE showed predictive value 
for new medical residents or inexperienced clinicians. Neither the survey or the LACE 
index identifies the patient's understanding of their disease process or provides evidence 




In addition to the LACE index, the use of predictive models such as the 
HOSPITAL predictive score may provide insight into the risk of unnecessary hospital 
readmission. Aubert et al.’s (2017) retrospective study evaluated the prognostic value of 
the simplified HOSPITAL score for predicting 30-day hospital readmission. This 
predictive model involves using seven clinical variables a discharge: hemoglobin levels, 
cancer diagnosis, sodium levels, nonelective admission, number of admissions in the past 
12 months, and hospital length of stay. This model allows for the prediction of avoidable 
hospital readmission, and this score may be calculated prior to hospital discharge. While 
this demonstrated a predictive model of CHF patients at increased risk, there is limited 
evidence regarding interventions for this at-risk population.  
Predictive models may also assist with the identification of patients at risk, as 
patients with CHF may benefit from palliative care. Fasolino and Phillips’ (2016) 
retrospective analysis used the risk readmission assessment tool (RRAT) and the need for 
palliative care in this patient population. The use of this tool allows for incorporating 
nonhospice palliative care (NPHC) to improve quality of life for CHF patients and their 
families. NPHC provides for a multidisciplinary approach to care, addressing physical, 
emotional, and spiritual needs of patients. The use of NPHC aids in symptom 
management of this at-risk population, while establishing goals for end-stage heart failure 
patients and assisting with enrollment into hospice if and when appropriate.  
The use of predictive models allows for identification of patients that may be at 
increased risk for readmission. While these risk stratification tools demonstrate predictive 




Predictive models, such as the LACE index tool, incorporate comorbid conditions that 
may increase the patient’s risk for hospital readmission. Limitations of this tool include 
age of the patient, gender, demographics such as socioeconomic status, and ethnicity. 
While these limitations play a role in the patient’s condition, they influence the outcome 
of predictive score.  
Transitional Care Model 
Koser, Ball, Homa, and Mehta (2018) conducted a retrospective chart review 
aimed at the development of an ambulatory heart failure clinic to reduce hospital 
readmission. Patients with a primary or secondary diagnosis of CHF were admitted to this 
clinic. The initial visit included detailed evaluation, monitoring at designated intervals, 
access to care, and aggressive management of symptoms in the ambulatory setting. 
Implementation at this clinic included an interdisciplinary team that evaluated patients 
prior to discharge to assess barriers to adherence to treatment regimens and 
acknowledgment of follow up appointments. At the first ambulatory appointment, 
patients were provided with tools such as a blood pressure cuff and scale to ensure that 
they were able to follow their blood pressure and weights accurately. In addition, the 
nursing staff contacted the patient weekly by phone for 60-days post-discharge. 
Hudali, Robinson, and Bhattarai (2017) discussed efforts to reduce hospital 
readmission and costs associated with this readmission through the use of a transitional 
care clinic facilitated by a hospitalist care team. Statistical significance was demonstrated 




of this clinic allows for early intervention post-discharge, assisting patients with 
educational needs, and reviewing medications.  
The use of transitional care models allows for the translation of evidence into 
practice and improving patient outcomes. Interventions include close follow up, use of 
multidisciplinary teams, and coordination of care lower the patient’s risk for hospital 
readmission. Implementation of a CPG allows for continuity of care across disciplines, 
increases efficiency, optimizes care, ultimately decreases the need for hospital 
readmission.  
Barriers to Care 
Ahmad et al. (2019) conducted a qualitative study to evaluate experiences and 
perceptions of patients with congestive heart failure, their caregivers, and the healthcare 
team. Using a free listing approach, respondents were asked open ended questions, then 
asked to provide a list of words related to the prompt and provide an order of importance 
of these items. The results were then triangulated between the patient, caregiver, and the 
healthcare team to create a better understanding of reasons for hospital readmission.  
This study allowed for identification of target areas for further interventions to reduce the 
need for hospital readmission. Key areas identified were related to patient 
teaching/education, barriers and priorities for self-care, adherence to therapeutic 
regimens, communication and management of symptom burden. Barriers identified by 
healthcare providers included assessment of management related to functional status, 
ability to perform activities of daily living, and individual personal influences on care 




teams identified areas of improvement related to self-care, management of symptoms, 
action plans when symptoms change, and patient perception of the need for hospital 
readmission.  
Trivedi et al.’s (2019) qualitative study examined barriers to self-care and 
management of CHF. Key points that emerged included fragmented or poorly 
coordinated care, concern for organizational barriers to care, barriers to collaborative 
practice, sources of conflict, and successful strategies to overcome barriers. CHF patients 
and healthcare providers noted the key concept of lack of knowledge in self-care as 
detrimental to the patient’s health status. Common themes were further identified based 
on a coding system that clarified barriers to self-care and the strategies to overcome these 
barriers. The patient identified barriers included lack of knowledge in self-care, lack of 
information materials, disempowerment related to symptom management, and ineffective 
communication between patient, primary caregiver, and healthcare team. Healthcare 
provider identified barriers included lack of standardized protocols, lack of knowledge 
with medication use and purpose, the concern that current care practices do not align with 
guideline care, communication with patient at time of discharge, coordination of care at 
discharge, and provider to provider communication. Limitations noted by Trivedi et al. 
(2019) that all CHF patients in the study were male. It was also noted race concordance 
between patient and provider aligned with adherence to the treatment plan.  
Ryan, Bierle, and Vuckovic (2019) summarized existing data from multiple 
registries that have identified preventable or unpreventable hospital readmissions and 




is not sufficient to address the complexity of CHF patients; the transition of care should 
be multidisciplinary with a focus on the discharge process. Discharge planning should 
include self-management of the disease process, patient education, evaluation of 
biomarkers, identification of comorbidities, assessment of the patient’s perception of the 
quality of life, and depression screening. Overcoming obstacles that may interfere with 
transition of care have been identified into common themes, demonstrating a 
multidisciplinary approach to post-hospital care.  
Identification of barriers to care allows practitioners to assess the needs of the 
patients and their families. These barriers may highlight inefficiencies in quality of care, 
use of guideline-directed therapy, and optimal medical management of patients with 
CHF. Lack of evidence-based care may not be reflective of the quality of care; however, 
it leads to ineffective transitioning, placing the patient at risk for unnecessary hospital 
readmission. 
Palliative Care  
Hupcey, Kitko, and Alonso (2016) conducted a longitudinal study to evaluate the 
patient’s perceptions of the severity and terminality with advanced heart failure. These 
patients had a predicted survival rate of fewer than two years. The sample size included 
100 patients with advanced heart failure, with 40% of these patients with a less than one 
year expected rate of survival (Hupcey, Kitko, & Alonso, 2016). Using a patient-centered 
approach, the healthcare team implemented a multidisciplinary approach that included 
the use of palliative care. The use of palliative care with this patient population allows for 




of life. Survival rate of the patients included in the study was less than 2 years. Majority 
of patients included did not perceive heart failure to be a terminal disease process. This 
perception affected the incorporation of palliative care into the care process for these 
patients.  
Diop et al. (2017) noted the complexity of patients with CHF and the use of a 
multidisciplinary approach allows for incorporating care that impacts the patient 
physically, cognitively, and socially. To provide patient-centered care, the management 
of these patients requires individualized care-planning, communication, and the use of 
palliative care. This systematic review assessed the effectiveness of palliative care and 
interventions for heart failure patients (Sidebottom et al., 2015; Wiskar et al., 2017). It 
was noted that as this patient population continues to progress toward advanced disease 
processes, the implementation of palliative care is imperative. Interventions that 
incorporate self-care, team-based palliative care along with heart failure management, 
improve patient outcomes as well as decrease health care costs and the utilization of 
resources, needed by hospital readmission (Chuang et al., 2016).  
Chronic Care Model 
The chronic care model provides a framework in the management of patients with 
chronic illness. Ballo et al. (2018) evaluated the use of this framework through a cohort 
study to determine the prognostic impact in chronically ill patients. Patients identified for 
were evaluated by a general practitioner at routine intervals, received counseling 
regarding lifestyle modifications, placed on guideline-directed medication therapies, and 




referral to specialty care, including cardiology and the input of appropriate diagnosis 
coding for congestive heart failure. There is prognostic support in the use of the chronic 
care framework, demonstrating a decrease in mortality, but an increase in hospitalization.  
Implementation of the chronic care model in the CPG allowed for ongoing 
interaction and interventions in patients with congestive heart failure. This chronic illness 
requires daily adjustments in self-care, self-monitoring, and self-management 
(Francesconi et al., 2019). Changes in care, monitoring, or management may require 
alterations in the treatment plan, communication, and interaction with the healthcare 
team. The chronic care model allows for daily management and early intervention, 
leading to decreased risk for unnecessary hospital readmission.  
Definitions of Terms 
Though there are many terms in common usage in the DNP project, perhaps 
clarification is needed regarding the use of the word project within the context of the 
DNP project and the organization’s QI initiatives. The focus of the DNP project is to 
develop a CPG as to support the organization’s QI initiative. As QI initiatives are also 
called QI projects, I offer this clarification. Although the organization has had a QI 
project team that I have been a member of for several months, the DNP project is an 
extension of that work, with the development of the CPG.  
Relevance to Nursing Practice 
Heart failure readmission and patient outcomes impact the patient, as well as 
those providing care for this patient population. Research has demonstrated the impact of 




by this chronic illness is expected to increase over the next 10 years. Although patients 
have been identified through the use of predictive tools such as the LACE index too, 
practice site readmission rates remain elevated beyond the national average.  
As patients are identified by individual risk and through risk stratification, several 
factors contribute to unplanned hospital readmission, including system factors of early 
discharge from the hospital, lack of symptom management by non-heart failure 
specialists during admission, and lack of support services post-discharge. Targeted 
interventions such as care coordination and transitional care programs have shown some 
improvements in readmission rates; however, the risk for readmission remains. Jun and 
Faulkner (2018) noted interventions with the utilization of multi-disciplinary teams 
including referral to heart failure specialists and face-to-face communication, have been 
demonstrated to reduce the risk for readmission. Nurses also play a significant role in 
patient outcomes. Nurses provide continuous care of these complex patients, engage in 
medication administration, and provide education on therapies, symptom management, 
and self-care. Additional system factors that may contribute to hospital readmission and 
patient outcomes is the patient-to-nurse ratio, work environment, and nursing knowledge 
of congestive heart failure. 
Herrin et al. (2015) conducted an observational study to further understand the 
barriers that lead to hospital readmission. Focusing on patient-level barriers such as 
health literacy, and social support, noting the specific barriers of living alone, 
employment status, and educational level, CHF patients demonstrated an increased risk 




as access to specialty care, and were also associated with lower hospital readmission 
rates. Understanding these risks for readmission and the barriers that congestive heart 
failure patient’s face allows for implementation of a multi-disciplinary CPG to reduce the 
risk for hospital readmission.  
There is ample research evidence that supports the development of a practice 
guideline focused on coordinating efforts organizationally to assure that patients are 
adequately prepared for discharge and have access to resources that can ease the 
transition. Prediction of risk for readmission allows healthcare teams to ensure that the 
patients’ needs are being assessed and addressed based on their potential risk for 
readmission. Identification of comorbidities, common characteristics, evidence of social 
support, and individual behaviors play a role in patients’ predictive risk for readmission 
(Ritt & Taylor, 2016; Mirkin, Enomoto, Caputo, & Hollenbeak, 2017; Flanagan et al., 
2018). 
Building on the potential risk for readmission, healthcare teams must understand 
challenges for both patients and the healthcare system. These barriers may lead to 
readmission, affect the quality of life for the patient and their family members, and 
increase the risk of mortality. The HRRP allows organizations to identify patient 
populations that have a higher than expected risk for readmission and implement care 
guidelines that reduce this risk and assist patients in overcoming barriers to care. 
Reducing patient level and system level barriers allows the patient and their healthcare 




readmission (McIlvennen, Eapen, & Allen, 2015; Ziaeian, & Fonarow, 2016; Sevilla-
Cazes et al., 2018; Wood et al., 2019). 
Transitioning patients from hospital to home requires the efforts of a multi-
disciplinary team. This transition includes the timeliness of outpatient follow up, 
coordination of care from hospital to home, communication, and self-care. Incorporating 
palliative care in this transition, allows for goal setting that is realistic and empowers to 
the patient to be an active participant in their care (Donaho et al., 2015; Koser, Ball, 
Homa, & Mehta, 2018; Hudali, Robinson, & Bhattarai, 2017). Through an evidence-
based CPG, CHF patients are identified, risk stratified, and placed on a heart failure 
pathway that allows for increased self-care, reduction in hospital admission, and 
improvement in their quality of life. 
Local Background and Context 
CHF affects more than six million individuals and accounts for more than 
700,000 hospitalizations annually (Mirkin, Enomoto, Caputo, and Hollenbeak, 2017). 
Many of these patients are readmitted to the hospital within 30-days, with an additional 
increase in readmission at 90-days. In 2018, the readmission rate for patients with 
congestive heart failure, exceeded the national average of 21.7%. Reducing this 
readmission rate below the national average aligns with the mission and goals of the 
practice site.  
Patients at increased risk are noted to have lower socioeconomic status, be 
uninsured, and be greater than 65 years of age. The project setting is a 208-bed facility 




population of more than 3 million individuals. The population served by this facility is 
more than 500,000 patients, accounting for more than 100,000 admissions and emergency 
room visits annually. This demographic includes predominately non-Hispanic whites, 
higher household median income than other regions in the state, the lowest number of 
uninsured individuals, and only 16% of the population do not have transportation.  
Despite significant efforts over the past six months, the 30-day readmission rate at 
the site remains higher than the national average. Strategies including use of the LACE 
predictive model and establishing a post-discharge clinic have not been successful to 
date. These initiatives have not been well coordinated or implemented across the facility 
as they involve varied departments and personnel. Thus, the purpose of the DNP project 
is to close the gap in practice, develop a practice-guideline that can potentially pull all of 
the disjointed pieces together in a coordinated way, and answer the practice-focused 
question: Will a transition of care practice guideline be accepted for full implementation 
by an expert panel at this site as a strategy to reduce this 30-day readmission rate in heart 
failure patients? 
Role of the DNP Student 
CHF is one of the most common health concerns that I see in daily practice. As a 
cardiovascular advanced practice nurse, working to improve the lives of this patient panel 
is a daily endeavor. Patients with CHF deal with the day-to-day self-management of a 
disease process that can affect their overall well-being. This ongoing management can 
lead to decompensation with small changes in their dietary regimen, missed doses of 




The role of the DNP student is to ultimately close a gap in practice through the 
DNP project. The site for the project is affiliated with my place of employment; however, 
I am not directly employed at this site, minimizing the potential bias for the project. 
Implementation of the CPG has the potential to change clinical practice through the 
implementation of evidence-based practice, improved communication, and improved 
coordination of care. This DNP project has the potential for bridging the gap in nursing 
practice leading to a change in culture at the clinical site. These changes lead to decreased 
need for hospital readmission, improved coordination of care, improved communication 
between the patient and the healthcare team, and empowerment of the patient, leading to 
positive social change in caring for patients with chronic congestive heart failure.  
Role of the Project Team 
Current readmission rates for CHF patients remain above the national average, 
despite efforts to coordinate care and transition patients to home. Efforts to reduce the 
current 30-day readmission rate have been well-intentioned, but not coordinated. Use of a 
CPG bridges the gaps in knowledge to ensure that care is coordinated between healthcare 
teams, opens lines of communication, and allows for implementation of guideline-based 
therapies.  
For the DNP project, and as the DNP project leader, I presented the CPG to an 
expert panel derived from the QI team at the site seeking their discussion, feedback and 
ultimately, their approval to fully implement. The panel included the heart failure 
physicians, heart failure advanced practice providers, members of the quality 




management, and the cardiology medical director. This team creates a bridge between 
hospital leadership and the care teams, working to align national initiatives with network 
goals in the care of heart failure patients. The expert panel served a dual purpose, as their 
roles as part of this interdisciplinary team include their leadership as well as their care at 
the bedside for these complex patients. This team not only impacts the implementation of 
care, but also plays a role in the ongoing evaluation of quality metrics, as well as care of 
the patient.  
Summary 
The gap in practice identified is the need for reducing hospital readmission in 
patients with CHF. The results of the literature demonstrate that communication and 
coordination of care based on evidence and guideline-directed therapies should be used 
when working to reduce hospital readmission and improve patient outcomes. Patients 
with congestive heart failure are often complex, requiring a multidisciplinary approach to 
care. The use of a CPG should be implemented to reduce the risk for hospital 
readmission, improve communication and coordination of care, and improve the quality 
of life for patients with congestive heart failure. This DNP project will collect and 
analyze data, demonstrating the gap in practice and the project site and will be addressed 
through the CPG. Section 3 will provide details into the methods used to develop the 




Section 3: Collection and Analysis of Evidence 
Introduction 
CHF is one of the leading causes of hospital admission and readmission, affecting 
more than a million patients annually. Initiatives from CMS include the enforcement of 
penalties to hospitals and healthcare systems with increased 30-day all-cause 
readmission. Research at the practice site has demonstrated the use of predictive models, 
use of targeted interventions, and coordination of care to reduce the risk for hospital 
readmission, yet despite these efforts, the 30- day readmission rate remains elevated 
beyond national average (Flanagan et al, 2018; Ritt & Taylor, 2016). Implementation of a 
CPG translates evidence into practice to improve the quality of life for patients with 
chronic congestive heart failure and has the potential to decrease the influences that 
contribute to hospital admission and readmission  
CHF is a chronic disease requiring ongoing daily management that leads to 
increased risks for hospital readmission. The CMS established the HRRP to reduce 
payments to hospitals with increased 30-day readmission rates. Due to this initiative, 
healthcare systems have been evaluating methods to identify patients who may be at risk 
and implementing interventions that potentially reduce the need for hospital readmission. 
This reduction of risk for hospital readmission requires a multifaceted approach. A CPG 
involves using predictive risk models to risk-stratify patients, identify patient and system 
barriers, and include methods to overcome barriers that patients and healthcare systems 




increased readmission rates through a CPG that will more accurately define and 
coordinate transition of care processes for CHF patients. 
Practice-Focused Question 
The practice-focused question is: Will a transition of care practice guideline be 
accepted for full implementation by an expert panel at this site as a strategy to reduce this 
30-day readmission rate in CHF patients? The gap in practice identified is the need for 
reducing hospital readmission, yet with the use of predictive models, transitional care 
clinics, and close follow up, readmission rates remain elevated beyond the national 
average of 21.7%. The DNP project bridges the gap in practice through a CPG that more 
accurately defines the transition of care process for CHF patients, reducing the risk for 
hospital readmission.  
Sources of Evidence 
Published Outcomes and Research 
 The CPG is based on evidence and involves reducing risks for hospital 
readmission. Sources of evidence for the CPG consist of literature that allows for risk 
stratification of patients with congestive heart failure at risk for readmission. This CPG 
also acknowledges patient and system barriers, allowing for the implementation of 
targeted interventions, including the use of palliative care and transitional care clinics to 
reduce risks for hospital readmission. The literature review included the database and 
search engines CINAHL Plus, Medline, ProQuest. Key search terms included: heart 
failure, cardiac failure, CHF, chronic heart failure, congestive heart failure, 




readmission, LACE index, patient barriers, obstacles or challenges, and palliative care. 
Limitations of searched articles included full-text articles, published within the last five 
years, and conducted in the United States.  
Evidence Generated for the Doctoral Project 
Participants. Participants who contributed to reviewing the practice-focused 
question included a multidisciplinary practice site expert panel.  This panel was 
comprised of practice site heart failure physicians, and heart failure advanced practice 
providers, members of the acute care quality improvement team, an acute care data 
analyst, nursing leadership, cardiac rehabilitation, case management, and the cardiology 
medical director. This team not only provides care at the bedside, members of this team 
guide implementation of the CPG.  
Procedures. The development of the CPG was based on evidence. Presentation of 
the CPG to the expert panel allowed for input and feedback based on expert opinions of 
members. The CPG was presented along with an algorithm for reducing the risk of 30-
day hospital readmission. Upon a patient’s presentation to the emergency department, the 
LACE score is calculated, and diagnostic workup is initiated. If admission is deemed 
necessary, patients are admitted to the medicine team with a consult to cardiology. The 
current heart failure order set does not include a consult to cardiology. Initiating this care 
team early in the process allows for implementation of guideline directed medical therapy 
(GMDT) and continuity of care in the ambulatory setting. In patients with new onset 
heart failure, further diagnostics with cardiology may be necessary including possible 




allows for further implementation of guideline-directed medical therapies. Additional 
consults to ancillary services that will assist in the assessment of patients as well as case 
management/social services, pharmacy, nutrition, cardiac rehab, transitional care nursing, 
and palliative care allow for a comprehensive and multidisciplinary approach to assessing 
potential risks and barriers to care for these patients. At the time of discharge, the use of a 
CHF checklist allows for documentation and data gathering of guideline- directed 
therapies and medication reconciliation, as well documentation of the needs assessments 
and ambulatory follow up (see Appendix B).  
The development of the CPG involved the use of the AGREE II instrument that 
assesses for methodological rigor (see Appendix C). This instrument provides a 
framework for assessing the quality of the CPG and how information is reported within 
the CPG. This tool consists of 23 items in six domains focused on each component of the 
CPG. Members of the expert panel completed the tool scoring each domain using the 
seven-point scale. A summation of the domain scores are included in the findings and 
recommendations (Brouwers et al., 2010). Permissions to use this tool were also obtained 
(see Appendix D). 
Following presentation of the CPG, members of the expert panel were asked to 
complete the AGREE II instrument, and additional input was obtained from the expert 
panel using the Delphi technique. These rounds of questions involved information 
gathering regarding what solutions would be effective in the guideline, how to monitor 
progress following implementation of the CPG, including a timeline for full 




Planning for possible barriers that may hinder implementation include utilization 
of resources: Currently there is no inpatient cardiac rehab at each facility, which places 
the emphasis of heart failure education on practitioners or nursing. How will we complete 
60-minutes of education with a patient? How is the CPG different than what we are 
currently doing? Resources are different at each facility; how do we expect to meet the 
needs for education? Can low risk patients be managed by the medicine team? How does 
the transitional care clinic apply to the clinical guideline? A brief summary of the open-
ended questions used in the qualitative discussion is found in Appendix E. 
Protections. The Walden IRB process and manual were followed, as well as the 
organizational IRB process in the development and presentation of the CPG to the expert 
panel (Manual for clinical practice guideline development, 2019). The site IRB provided 
exempt approval number 64183 on February 26, 2020 and Walden University’s IRB 
approval was obtained with the approval number 01-16-20-0064183. Members of the 
expert panel were asked to participate in the presentation and discussion, and their 
anonymity was protected. No incentives were offered for involvement in the process. No 
communication with the expert panel was conducted until the completion of the IRB 
process for Walden University, as well as the practice site (U.S. Department of Health & 
Human Services, 2018).  
Analysis and Synthesis 
Rating on the AGREE II instrument was summarized using descriptive statistics. 
Interrater reliability among the expert panel participants was established using SPSS v26. 




discussion and overall support (or lack thereof) for the practice guideline. The Delphi 
method allows for communication and feedback (Wilkes, 2015). Using this method 
allows for the development of the CPG to reduce the risk for heart failure readmission. 
The guideline involves evidence-based practice, feedback from an expert panel, and the 
willingness of this group of stakeholders to proceed with full implementation of the CPG. 
The Delphi methodology was used in the presentation of the guideline, which includes 
the use of open-ended questions and feedback (see Appendix E). As part of the 
presentation, the DNP project provided the evidence, rationale, and algorithm to identify 
tools to risk stratify patients, obstacles, and barriers for both the patient and the healthcare 
system, as well as interventions that allow for the implementation of guideline-directed 
therapies that reduce the risk for unnecessary readmissions. 
Summary 
The DNP project proposed is the development of a CPG to reduce readmission for 
patients with congestive heart failure. This project was developed and was presented to 
an expert panel of heart failure specialists and stakeholders involved with the care of this 
at-risk patient population. The project was presented to the expert panel for review, 
discussion, and approval for full implementation at the clinical practice site. Section 4 




Section 4: Findings and Recommendations 
Introduction 
The development of a CPG for reducing heart failure readmissions is aimed at 
improving the care of patients with heart failure while bridging a gap in nursing practice, 
leading to changes in the culture of care at the clinical site. These changes lead to 
decreased need for hospital readmission, coordination of care, improved communication 
between patients and healthcare teams, and empowerment of patients. In addition, these 
changes have the potential to lead to a reduction in hospital admission and readmission, 
ultimately decreasing in-hospital mortality and morbidity in patients with chronic CHF. 
The purpose of the DNP project was to develop a CPG to reduce heart failure 
readmission. This CPG was developed using the LACE risk stratification tool, evidence-
based practice guidelines for CHF, heart failure order sets, and transitional care services 
designed specifically for patients with CHF. With the reinforcement of the HRRP from 
the CMS, reducing heart failure readmissions helps bridge the gap in practice and more 
accurately define the transition of care process for CHF patients at the site. This CPG 
involves closing the gap in practice through implementation of strategies to reduce 30-
day readmissions in CHF patients. 
Findings and Implications 
The DNP project not only demonstrates the potential positive impact for the 
organization, but also the positive impact for patients and their families as well as the 
healthcare system. Decreasing heart failure readmissions keep patients at home and lower 




approach and standardization of processes in caring for patients with CHF (Wood et al., 
2019). While the practice site represents one facility within a five-hospital campus 
system, resources vary at each of the five facilities. Using this multidisciplinary team 
allows each facility to adapt the CPG to effectively use resources while remaining 
fiscally responsible.  
The CPG was presented to a panel of nine local experts. These experts 
participated in a one-hour overview and discussion of the CPG. Once the presentation 
was concluded, the 23-item Agree II survey was sent electronically via SurveyMonkey® 
to 9 members of the team. There were nine surveys returned for analysis. The majority of 
participants agreed (6) or strongly agreed (7) on all domains except four domains: 
stakeholder involvement, rigor of development, applicability, and editorial independence. 
One respondent scored these with a response of five which indicates a mild level of 
disagreement. One respondent provided no response to domain six.  
Data gathered using the Agree II instrument allows for objective evaluation of the 
CPG. The score of each respondent allows for determining the quality of the CPG to be 
implemented. Scoring of the instrument using a numeric scale, from 1 (strongly disagree) 













Scope and Purpose 6.81 
Stakeholder Involvement  6.51 
5. The views and preferences of the target population (patients, public, etc.) have 
been sought. 
5.8 
Rigor of Development 6.33 
8. The criteria for selecting the evidence are clearly described. 5.8 
13. The guideline has been externally reviewed by experts prior to its publication. 6.1 
14. A procedure for updating the guideline is provided. 5.5 
Clarity of Presentation 6.70 
Applicability 6.47 
20. The potential resource implications of applying the recommendations have been 
considered. 
6.4 
21. The guideline presents monitoring and/or auditing criteria. 6.3 
Editorial Independence 5.91 
22. The views of the funding body have not influenced the content of the guideline. 5.8 
23. Competing interests of guideline development group members have been 




The Delphi method with the expert panel addressed the practice-focused question: 
Will a transition of care practice guideline be accepted for full implementation by an 
expert panel at this site as a strategy to reduce this 30-day readmission rate in CHF 
patients? The expert panel members were asked six open-ended questions pertaining to 
the CPG (see Appendix E). Discussion of these questions included current processes, 
implications regarding heart failure readmission, and how the GPG reflects use of 
guideline-directed therapy.  
After review of the CPG, the expert panel discussion included the need for 
detailed information regarding criteria for admission and ischemic workup (including 




consulting cardiologist. Low acuity patients will continue to be followed in the 
ambulatory setting by the primary care physician. If the need arises, an ambulatory 
consult to cardiology may be placed. These changes to the CPG are supported by directed 
therapies of the American College of Cardiology (ACC) and the American Heart 
Association (AHA) guidelines for managing heart failure (Yancy et al., 2017, American 
Heart Association, 2017). The discussion reflected incorporating evidence-based practice, 
improving the culture of care, and methods on reducing 30-day hospital readmissions. 
The expert panel engaged in a robust discussion regarding the CPG. For the most 
part, the discussion was very positive. One member of the panel stated, “sounds like the 
CPG will help us to reduce readmissions for heart failure patients”. Another member of 
the expert panel stated, “I think it will work.” However, there was also some debate that 
ultimately required some refinements to the CPG. For example, there was discussion 
about the need for defined criteria demonstrating the need for hospital admission when 
patients present to the emergency department. These criteria were defined as elevation of 
ProBNP, evidence of pulmonary edema on chest x-ray, LACE score of greater than 5, 
elevated troponin, and physical exam evidence of volume overload. These criteria 
demonstrate patients’ needs for more aggressive therapies than what could be provided in 
the emergency department. Revisions to CPG reflect recommendations of the expert 
panel (see Appendix F). 
Additional debate ensued regarding the need for an automatic consult to 
cardiology for patients admitted with a diagnosis of CHF. Referral to the specialty care of 




coordination of care at discharge. In addition, this patient population often needs an 
ischemic workup that may include stress testing, echocardiography, and coronary 
angiography. Workup may be completed during current hospitalization or deferred to the 
ambulatory setting to allow for recovery from acute illnesses. Involving cardiology at 
admission allows for early intervention, implementation of evidence-based therapies, and 
use of a multidisciplinary team of providers to care for patients while hospitalized, as 
well as in the ambulatory setting. Potential concerns involve coordinating care with 
primary care providers, as some of these providers are not affiliated with the network. 
This creates obstacles with obtaining ambulatory data to determine if patients are 
following up as outlined in the CPG, as well as continuing with GMDT as prescribed 
prior to discharge.  
Additional discussion with the expert panel included agreement across the board 
that the use of the multidisciplinary approach to care would be effective; however, with 
financial constraints and variability of resources in facilities, implementation of the CPG 
should be phased in over a 3-month period of time. The initial phase of implementation 
includes education and awareness of the practice guideline for providers (physician and 
APP) in the emergency department, hospitalists, and the cardiology department. 
Additional teams included in the implementation of the CPG include case management, 
pharmacy, nursing (including transitional care nursing), clinical informatics, and cardiac 
rehabilitation. Communication includes changes in workflow that are organization and 
provider-focused, education materials, current guidelines, and protocols for 




processes while the patient is hospitalized, use of the multidisciplinary team, further 
engagement of staff, and use of detailed protocols implemented into the EHR.  
Recommendations 
The nine-member expert panel unanimously recommended full implementation of 
the CPG. As part of this recommendation, a modified for phased implementation plan 
should occur over a three-month period, with education, data collection, and evaluation. 
The initial one-month phase includes education for providers in primary care, emergency 
department, cardiology providers, and hospitalists. Education will also occur with 
nursing, cardiac rehabilitation, case management, transitional care nursing, pharmacy, 
and the QI team, which also includes data analysts. Education for these departments 
includes presentation of current hospital readmission rates, practice site goals for hospital 
readmission, heart failure guidelines, and the CPG. 
In phase two of implementation, data collection included 50 patients presenting to 
the emergency department with a primary diagnosis of congestive heart failure. Criteria 
have been outlined in the CPG to assist providers with determining if hospital admission 
is recommended or aggressive diuresis is needed while the patient is in the emergency 
room. Prior to discharge from the emergency department, criteria determine the pathway 
for ambulatory follow up for patients based on their LACE score.  
The next phase of implementation a multidisciplinary team will be involved in 
with CHF patients who are admitted acute exacerbation of heart failure. At the time of 
admission and initiation of the CPG, a consult is placed to cardiology. In patients with 




ejection fraction (EF), the cardiologist will determine the treatment plan including 
ischemic workup and implementation of guideline directed therapy. As guideline directed 
medical therapy is initiated, the multidisciplinary team will be consulted for care 
coordination and optimization of treatment. In patients with an EF< 30%, a consult to 
electrophysiology and heart failure physicians will also be placed. Consultation with 
these subspecialties is initiated for ongoing follow up in the ambulatory setting.  
Strengths and Limitations of the Project 
Strength of the DNP project included the development of a CPG that can be used 
across disciplines. This guideline demonstrates the use of a multidisciplinary team to 
identify patients that are at increased risk for readmission, criteria for patients that require 
hospital admission, use of the multidisciplinary team, and demonstration of guideline 
directed therapies. The algorithm for the CPG provides detailed steps for each phase of 
care, including hospitalization and transition to home. This project uses the Agree II 
instrument for the assessment of methodological rigor. 
Limitations of the DNP project focused on inclusion of cardiology in the 
management of congestive heart failure patients, however education of the 
multidisciplinary team is needed for effective use of the CPG. This project will not 
demonstrate the impact on 30-day hospital readmission until further evaluation following 
the implementation of the practice guideline. Tracking and effectiveness through data 





Collaboration, communication, engagement of staff, and effective use of 
resources allows for implementation of evidence-based practice. As a multidisciplinary 
team, the CPG provides guidance in caring for patients with CHF. This guideline 
promotes positive social change by improving patient outcomes, decreasing mortality and 
morbidity, while decreasing heart failure readmissions. The differentiation in the CPG to 
reflect ischemic workup allows for broad work up to include, but not limited to stress 
testing and cardiac catheterization. Additional recommendations of the expert panel 
included implementation of tailored therapies for each patient. Identification of potential 
barriers allows for directing care and effective use of resources based on each facility. 
Coordination of care by consulting cardiology allows for building relationships and 
implementing care that may previously been delayed. Additional effective therapies 
include the use of pharmacy staff to verify and reconcile medications, as well as assist 
with education of medication therapies. Inclusion of case management allows for early 
identification of social barriers that may influence care after discharge, such as 
transportation, support, and ability to afford care/medications.  
Through implementation of the guideline, data collection will include evaluation 
of the LACE score, which demonstrates a decreasing risk for hospital admission. 
Additional data collection includes long-term evaluation of the CPG to determine if a 
decrease in hospital readmission is occurring. Decreasing the LACE score is reflective of 
decreasing hospital readmissions. As part of the CPG, long-term evaluation will occur for 




readmissions. The practice site will be responsible for ongoing evaluation and updating 
of the CPG reflecting changes or updates in GMDT.  
Education across disciplines of the CPG allows for care coordination. 
Consultation to cardiology at time of admission decreases the need for nursing staff to 
ask for specialty consultation for the care of CHF patients. Implementation of the CPG 
for all CHF patients decreases potential conflict regarding care coordination. Current 
processes include consultation to cardiology; however, the order may not be placed, 
creating a delay in care.  
Education provided for patients may vary depending on discipline providing 
education. Resources vary per facility and may not include inpatient cardiac 
rehabilitation. To overcome this barrier, educational materials for patients should be 
standardized. Providing and documenting standardized education prior to discharge 




Section 5: Dissemination Plan 
CHF is a leading cause of morbidity and mortality, leading to hospital admission 
and readmission. Each of these readmissions creates a financial burden for hospitals as 
well as patients, leading to expenditures of greater than $10,000 per readmission (Bailey 
et al., 2019). With readmission rates that currently exceed the national average of 21.7%, 
the CPG provides awareness of current issues, strategies for overcoming barriers, and 
recommendations for communication, follow up, and access to care.  
Dissemination of this project includes a detailed presentation to the 
multidisciplinary team involved in the care of this patient population across a five-
hospital campus system. This team includes hospitalist and emergency department 
physicians and APPs, case management, nursing (bedside and transitional care), cardiac 
rehabilitation (inpatient and ambulatory), heart failure physicians and APPs, general 
cardiology physicians and APPs, clinical informatics, and the quality improvement team.  
Further dissemination of this DNP project includes presentation of the CPG to 
membership of the Heart Failure Society of America (HFSA) and American Association 
of Heart Failure Nurses (AAHFN) as well as presenting during the practice site 
cardiology annual symposium. Presentation of this project builds on DNP essentials as 
outlined by the American Association of Colleges of Nursing (AACN). These essentials 
address foundational components of advanced practice nursing, focusing on assessment, 
evaluation, collaboration, and the implementation of new care delivery models for target 
populations. These models of care influence organization, political, and economic 




Analysis of Self 
As a scholarly practitioner, the DNP process allows for professional and personal 
growth. Not only did this project allow me to expand my knowledge of CHF, it also 
afforded the opportunity to research literature on CHF, exam care processes, 
communication, and interactions with patients. As I gained a deeper understanding of this 
patient population, I also gained an enhanced understanding of the social determinants 
that affect patients daily. This awareness allows for working to improve care processes, 
but also promote evidence-based practice for patients. Guidelines direct care: however, 
we may not be able to meet these guidelines due to cost, patient literacy, access to care, 
or social support. Care providers must be innovative in terms of ways to care for patients 
while improving their quality of life.  
In addition to learning and growth as a scholarly practitioner, I was able to 
develop relationships of care with a multidisciplinary team. This team approach allows 
for promoting engagement in patient care and promotes effective transitions for our 
patients from hospital to home. This project has opened lines of communication and 
engagement of a multidisciplinary team, creating an awareness for the need to change the 
culture of care for CHF patients.  
As a clinician, the DNP process allows for developing clinical knowledge and 
implementation of clinical guidelines based on evidence into daily practice. These 
guidelines demonstrate therapies designed to improve patient outcomes and mortality. 
Managing CHF patients presents complex challenges, as these patients often present 




accomplished through education, daily management of therapies, detection of symptoms, 
and early intervention, ultimately decreasing the need for hospitalization. As a manager 
of the DNP project, this process allows practitioners to seek out ways to improve care of 
designated patient populations. Working to create new processes of care, demonstration 
of leadership through collaboration, critical analysis of research and evidence, and 
offering new care processes allows for advancing the nursing profession. The 
foundational components of the DNP focus on demonstrating transformational change in 
nursing.  
Summary 
This DNP project includes the development and implementation of a CPG to 
reduce 30-day CHF readmissions. The CPG was developed and presented to an expert 
panel at the practice site seeking their feedback and ultimately approval for full 
implementation of the CPG. The panel was comprised of CHF physicians, CHF APPs, 
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Appendix C: Agree II 
Domain 1. Scope and Purpose 
1. The overall objective(s) of the guideline is (are) specifically described.  
2. The health question(s) covered by the guideline is (are) specifically described.  
3. The population (patients, public, etc.) to whom the guideline is meant to apply is 
specifically described.  
Domain 2. Stakeholder Involvement 
4. The guideline development group includes individuals from all relevant professional 
groups.  
5. The views and preferences of the target population (patients, public, etc.) have been 
sought.  
6. The target users of the guideline are clearly defined.  
Domain 3. Rigour of Development 
7. Systematic methods were used to search for evidence.  
8. The criteria for selecting the evidence are clearly described.  
9. The strength and limitations of the body of evidence are clearly described.  
10. The methods for formulating the recommendations are clearly described.  
11. The health benefits, side effects, and risks have been considered in formulating the 
recommendations.  
12. There is an explicit link between the recommendations and the supporting evidence.  
13. The guideline has been externally reviewed by experts prior to its publication.  
14. A procedure for updating the guideline is provided.  
Domain 4. Clarity of Presentation 
15. The recommendations are specific and unambiguous 
16. The different options for management of the condition or health issue are clearly 
presented.  
17. Key recommendations are easily identifiable.  
Domain 5. Applicability  
18. The guideline describes facilitators and barriers to its application.  
19. The guideline provides advice and/or tools on how the recommendations can be put into 
practice. 
20. The potential resource implications of applying the recommendations have been 
considered.  
21. The guideline presents monitoring and/or auditing criteria.  
Domain 6. Editorial Independence 
22. The views of the funding body have not influenced the content of the guideline.   
23. Competing interests of guideline development group members have been recorded and 
addressed.  
Overall Guideline Assessment  
Items are measured on a scale of 1 to 7; 1 indicates strong disagreement, 7 equates to strong 












Appendix E: Questions Delphi Method 
1. What do you anticipate will be effective or ineffective in the guideline once 
implemented? 
2. How might we monitor progress following implementation of the clinical practice 
guideline? 
3. What is the timeline for full implementation? 
4 Resources are different at each facility, how could we overcome these differences?  
5. What organizational and patient barriers may hinder implementation? 






Appendix F: CPG (Revised) 
 
 
   Represents changes to reflect criteria for admission:  elevated ProBNP, elevated troponin, abnormal EKG, CXR –   
   demonstrating pulmonary edema, physical exam demonstrates acute exacerbation of CHF 
   Represents changes to reflect ischemic workup: cardiac catheterization changed per expert panel  
   recommendation to reflect ischemic workup  
 
